Acorda Therapeutics OverviewAcorda Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ACOR.
Quarterly EBIT
-$13.55M
↓ 7.81% YoY
As of Mar 31, 2024
Annual EBIT (TTM)
-$23.84M
↑ 31.58% YoY
Trailing 12 months ending Mar 31, 2024
Acorda Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for ACOR.
As of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024